Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia

Brain Research Bulletin

Volumn 83, Issue 3-4, 2010, Pages 86-92

  Prasad, K M ^a   Talkowski, M E ^c   Chowdari, K V ^a   McClain, L ^a   Yolken, R H ^d   Nimgaonkar, V L ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epistasis; Etiology; Gene environment; Gene gene; Interactions; Schizophrenia

Indexed keywords

4 AMINOBUTYRIC ACID; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DOPAMINE; GLUTAMIC ACID; NEU DIFFERENTIATION FACTOR;

ARTICLE; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC EPISTASIS; GENETIC VARIABILITY; GENOMICS; HEREDITY; HUMAN; INFECTION; PATHOGENICITY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA;

ANIMALS; ENVIRONMENT; EPISTASIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RISK FACTORS; SCHIZOPHRENIA;

EID: 77956650754     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2009.08.023     Document Type: Article

References (55)

1. Benzel I., Bansal A., Browning B.L., Galwey N.W., Maycox P.R., McGinnis R., et al. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav. Brain Funct. 2007, 3:31.
2. Burdick K.E., Kamiya A., Hodgkinson C.A., Lencz T., DeRosse P., Ishizuka K., et al. Elucidating the relationship between DISC1, NDEL1 and NDE1 and the risk for schizophrenia: evidence of epitasis and competitive binding. Hum. Mol. Genet. 2008, 17(August (16)):2462-2473.
3. Carter C.L., Chung C.S. Segregation analysis of schizophrenia under a mixed genetic model. Hum. Heredity 1980, 30(6):350-356.
4. Chan I.H., Leung T.F., Tang N.L., Li C.Y., Sung Y.M., Wong G.W., et al. Gene-gene interactions for asthma and plasma total IgE concentration in Chinese children. J. Allergy Clin. Immunol. 2006, 117(1):127-133.
5. Chen S.F., Chen C.H., Chen J.Y., Wang Y.C., Lai I.C., Liou Y.J., et al. Support for association of the A277C single nucleotide polymorphism in human vesicular monoamine transporter 1 gene with schizophrenia. Schizophr. Res. 2007, 90(1-3):363-365.
6. Chumakov I., Blumenfeld M., Guerassimenko O., Cavarec L., Palicio M., Abderrahim H., et al. Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(October (21)):13675-13680. (Epub 2002 October 3).
7. Cockerham C.C., Weir B.S. Covariances of relatives stemming from a population undergoing mixed self and random mating. Biometrics 1984, 40(1):157-164.
8. Collins A., Ennis S., Taillon-Miller P., Kwok P.Y., Morton N.E. Allelic association with SNPs: metrics, populations, and the linkage disequilibrium map. Hum. Mutat. 2001, 17(4):255-262.
9. Collins F.S. Positional cloning moves from perditional to traditional. Nat. Genetics 1995, 9(4):347-350.
10. Consortium T.I.S. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 2008, 455(September (7210)):237-241.
11. Cordell H.J., Clayton D.G. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am. J. Hum. Genet. 2002, 70(1):124-141.
12. Corvin A., McGhee K.A., Murphy K., Donohoe G., Nangle J.M., Schwaiger S., et al. Evidence for association and epistasis at the DAOA/G30 and d-amino acid oxidase loci in an Irish schizophrenia sample. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B(October (7)):949-953.
13. Cui Y., Kang G., Sun K., Qian M., Romero R., Fu W. Gene-centric genomewide association study via entropy. Genetics 2008, 179(1):637-650.
14. Culverhouse R., Klein T., Shannon W. Detecting epistatic interactions contributing to quantitative traits. Genet. Epidemiol. 2004, 27(2):141-152.
15. Culverhouse R., Suarez B.K., Lin J., Reich T. A perspective on epistasis: limits of models displaying no main effect. Am. J. Hum. Genet. 2002, 70(2):461-471.
16. DeWan A., Klein R.J., Hoh J. Linkage disequilibrium mapping for complex disease genes. Methods in molecular biology (Clifton, NJ). Methods Mol. Biol. 2007, 376:85-107.
17. Edwards T.L., Wang X., Chen Q., Wormly B., Riley B., O'Neill F.A., et al. Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia. Schizophr. Res. 2008, 106(2-3):208-217.
18. Egan M.F., Straub R.E., Goldberg T.E., Yakub I., Callicott J.H., Hariri A.R., et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(August (34)):12604-12609.
19. Fisher R.A. The correlation between relatives on the supposition of Mendelian inheritance. Trans. Roy. Soc. Edinburgh 1918, 52:399-433.
20. Gottesman I. Schizophrenia Genesis: The Origins of Madness 1991, WH Freeman, New York.
21. Howard L.M., Kumar C., Leese M., Thornicroft G. The general fertility rate in women with psychotic disorders. Am. J. Psychiatry 2002, 159(6):991-997.
22. Jannink J.L. Identifying quantitative trait locus by genetic background interactions in association studies. Genetics 2007, 176(1):553-561.
23. Kang G., Yue W., Zhang J., Huebner M., Zhang H., Ruan Y., et al. Two-stage designs to identify the effects of SNP combinations on complex diseases. J. Hum. Genet. 2008, 53(8):739-746.
24. Kim J.J., Dayal M., Bacanu S.-A., Shirts B.H., Wood J., Xie W., et al. Exposure to cytomegalovirus and polymorphisms in two genes on chromosome 6p21-23 as joint risk factors for schizophrenia. Am. J. Med. Genet. 2004, 130B(September (1)):19.
25. Kim J.J., Shirts B.H., Dayal M., Bacanu S., Wood J., Xie W., et al. Are exposure to cytomegalovirus and genetic variation on chromosome 6p joint risk factors for schizophrenia?. Ann. Med. 2007, 39:145-153.
26. Kvajo M., Dhilla A., Swor D.E., Karayiorgou M., Gogos J.A. Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol. Psychiatry 2008, 13(7):685-696.
27. Macgregor S., Khan I.A. GAIA: an easy-to-use web-based application for interaction analysis of case-control data. BMC Med. Genet. 2006, 7(1):34.
28. Marenco S., Steele S.U., Egan M.F., Goldberg T.E., Straub R.E., Sharrief A.Z., et al. Effect of metabotropic glutamate receptor 3 genotype on N-acetylaspartate measures in the dorsolateral prefrontal cortex. Am. J. Psychiatry 2006, 163(4):740-742.
29. Martin E.R., Ritchie M.D., Hahn L., Kang S., Moore J.H. A novel method to identify gene-gene effects in nuclear families: the MDR-PDT. Genet. Epidemiol. 2006, 30(2):111-123.
30. McGue M., Gottesman I.I., Rao D.C. The transmission of schizophrenia under a multifactorial threshold model. Am. J. Hum. Genet. 1983, 35(6):1161-1178.
31. Montag C., Hartmann P., Merz M., Burk C., Reuter M. D2 receptor density and prepulse inhibition in humans: negative findings from a molecular genetic approach. Behav. Brain Res. 2008, 187(March (2)):428-432.
32. Morris D.W., Murphy K., Kenny N., Purcell S.M., McGhee K.A., Schwaiger S., et al. Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): main and epistatic gene effects are potential contributors to schizophrenia susceptibility. Biol. Psychiatry 2008, 63(January (1)):24-31.
33. Nelson M.R., Kardia S.L., Ferrell R.E., Sing C.F. A combinatorial partitioning method to identify multilocus genotypic partitions that predict quantitative trait variation. Genome Res. 2001, 11(3):458-470.
34. Nicodemus K.K., Kolachana B.S., Vakkalanka R., Straub R.E., Giegling I., Egan M.F., et al. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: influence on risk of schizophrenia. Hum. Genet. 2007, 120(6):889-906.
35. Nicodemus K.K., Marenco S., Batten A.J., Vakkalanka R., Egan M.F., Straub R.E., et al. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol. Psychiatry 2008, 13(9):873-877.
36. Petronis A. The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol. Psychiatry 2004, 55(10):965-970.
37. Rao D.C., Morton N.E., Gottesman I.I., Lew R. Path analysis of qualitative data on pairs of relatives: application to schizophrenia. Hum. Heredity 1981, 31(6):325-333.
38. Risch N. Genetic linkage and complex diseases, with special reference to psychiatric disorders. Genet. Epidemiol. 1990, 7(1):3-16. (discussion 7-45).
39. Ritchie M.D., Hahn L.W., Moore J.H. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet. Epidemiol. 2003, 24(2):150-157.
40. Shirts B.H., Nimgaonkar V. The genes for schizophrenia: finally a breakthrough?. Curr. Psychiatry Rep. 2004, 6(4):303-312.
41. Skol A.D., Scott L.J., Abecasis G.R., Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 2006, 38(2):209-213.
42. St Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 1990, 336(8706):13-16.
43. Stefansson H., Rujescu D., Cichon S., Pietilainen O.P., Ingason A., Steinberg S., et al. Large recurrent microdeletions associated with schizophrenia. Nature 2008, 455(September (7210)):232-236.
44. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 2002, 71(4):877-892.
45. Straub R.E., Lipska B.K., Egan M.F., Goldberg T.E., Callicott J.H., Mayhew M.B., et al. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Mol. Psychiatry 2007, 12(9):854-869.
46. Talkowski M.E., Bamne M., Mansour H., Nimgaonkar V.L. Dopamine genes and schizophrenia: case closed or evidence pending?. Schizophr. Bull. 2007, 33(5):1071-1081.
47. Talkowski M.E., Kirov G., Bamne M., Georgieva L., Torres G., Mansour H., et al. A network of dopaminergic gene variations implicated as risk factors for schizophrenia. Hum. Mol. Genet. 2008, 17(March (5)):747-758.
48. Tan H.Y., Chen Q., Sust S., Buckholtz J.W., Meyers J.D., Egan M.F., et al. Epistasis between catechol-O-methyltransferase and type II metabotropic glutamate receptor 3 genes on working memory brain function. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(July (30)):12536-12541.
49. Tan H.Y., Nicodemus K.K., Chen Q., Li Z., Brooke J.K., Honea R., et al. Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. J. Clin. Invest. 2008, 118(6):2200-2208.
50. Velez D.R., White B.C., Motsinger A.A., Bush W.S., Ritchie M.D., Williams S.M., et al. A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction. Genet. Epidemiol. 2007, 31(4):306-315.
51. Yolken R.H., Torrey E.F. Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol. Psychiatry 2008, (February).
52. Zerba K.E., Kessling A.M., Davignon J., Sing C.F. Genetic structure and the search for genotype-phenotype relationships: an example from disequilibrium in the Apo B gene region. Genetics 1991, 129(2):525-533.
53. Zhang Y., Liu J.S. Bayesian inference of epistatic interactions in case-control studies. Nat. Genet. 2007, 39(9):1167-1173.
54. Zinkstok J., Schmitz N., van Amelsvoort T., Moeton M., Baas F., Linszen D. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia. Genes Brain Behav. 2008, 7(1):61-69.
55. Kooperberg C., Ruczinski I. Identifying interacting SNPs using Monte Carlo logic regression. Genet Epidemiol. 2005, 28(2):157-170.